ATE316379T1 - Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen - Google Patents

Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen

Info

Publication number
ATE316379T1
ATE316379T1 AT99943166T AT99943166T ATE316379T1 AT E316379 T1 ATE316379 T1 AT E316379T1 AT 99943166 T AT99943166 T AT 99943166T AT 99943166 T AT99943166 T AT 99943166T AT E316379 T1 ATE316379 T1 AT E316379T1
Authority
AT
Austria
Prior art keywords
acid
oxyhumic
treatment
various disorders
composition
Prior art date
Application number
AT99943166T
Other languages
English (en)
Inventor
Johannes Dekker
Constance Elizabeth Medlen
Original Assignee
Pfeinsmith Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfeinsmith Ltd filed Critical Pfeinsmith Ltd
Application granted granted Critical
Publication of ATE316379T1 publication Critical patent/ATE316379T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10Peat; Amber; Turf; Humus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Fertilizers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99943166T 1998-09-23 1999-09-22 Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen ATE316379T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA988731 1998-09-23
ZA991926 1999-03-10

Publications (1)

Publication Number Publication Date
ATE316379T1 true ATE316379T1 (de) 2006-02-15

Family

ID=27144962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99943166T ATE316379T1 (de) 1998-09-23 1999-09-22 Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen

Country Status (6)

Country Link
US (1) US6630179B1 (de)
EP (1) EP1115408B1 (de)
AT (1) ATE316379T1 (de)
AU (2) AU5643299A (de)
DE (1) DE69929616T2 (de)
WO (2) WO2000016785A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
WO2010020379A1 (en) * 2008-08-16 2010-02-25 Protectimmun Gmbh Composition for prevention and treatment of allergic and/or inflammatory diseases
RU2531945C2 (ru) * 2013-01-25 2014-10-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства Средство против передачи вич/спид половым путем
EP2878342A1 (de) 2013-11-27 2015-06-03 Latvijas Universitate Verfahren zur Extraktion von Torfwirkstoffen und Verwendung von deren Kombination in hautregenerierenden kosmetischen Formulierungen
RU2624851C1 (ru) * 2016-04-18 2017-07-07 Елена Николаевна Зайцева Средство, обладающее мочегонной активностью
RU2678986C1 (ru) * 2018-03-23 2019-02-05 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Противовирусное средство на основе гуминовых кислот
CN109504713B (zh) * 2018-12-04 2022-05-17 齐鲁工业大学 利用拜氏梭菌制备高酯键腐植酸制剂的方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225271A (en) * 1987-07-08 1991-02-26 Nat Energy Council Oxidising coal using a gaseous oxidant
DE3903773A1 (de) * 1988-02-11 1989-09-14 Nat Energy Council Eine mischung mit bakteriozider oder bakteriostatischer aktivitaet
DE69224024T2 (de) * 1991-03-16 1998-08-27 Torf Ets Torf-derivierte bioaktive produkte und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
DE539610T1 (de) * 1991-10-26 1993-12-16 Torf Ets Verfahren und Zusammensetzung zur Bestimmung der Immunologischen Aktivität von aktiven Substanzen enthaltende Lösungen.
AU7877894A (en) 1993-09-24 1995-04-10 Maurizio Zanetti Treatment of hiv infection with humic acid
ATE206163T1 (de) * 1994-04-22 2001-10-15 Corixa Corp Verbindungen und methoden für die stimulierungen und die erhöhung von schutzimmunantworten und il- 12 herstellung
US5945446A (en) * 1997-02-10 1999-08-31 Laubc Biochemicals, Corporation Process for preparing synthetic soil-extract materials and medicaments based thereon

Also Published As

Publication number Publication date
WO2000016785A2 (en) 2000-03-30
DE69929616T2 (de) 2006-07-27
WO2000016785A3 (en) 2000-05-25
AU5643299A (en) 2000-04-10
DE69929616D1 (de) 2006-04-13
AU5643499A (en) 2000-04-10
AU772123B2 (en) 2004-04-08
EP1115408A2 (de) 2001-07-18
WO2000016786A2 (en) 2000-03-30
EP1115408B1 (de) 2006-01-25
US6630179B1 (en) 2003-10-07
WO2000016786A3 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
DE69915458D1 (de) Dextran formulierungen zur behandlung entzündlicher gelenkerkrankungen
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
RU95109905A (ru) Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ATE265851T1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
AU3401093A (en) Therapeutic agent for threatened abortion
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
ATE295159T1 (de) Bupropion zur behandlung von viralen erkrankungen
ATE255890T1 (de) Pantothensäure-enthaltende arzneimittel zur behandlung von entzündlichen gelenkserkrankungen
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
RU93052444A (ru) Лекарственный препарат бан
RU92011168A (ru) Препарат для лечения гинекологических заболеваний
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
EA200000011A1 (ru) Средства и способы доставки лекарственных препаратов для терапии вирусных и бактериальных инфекций и синдромов истощения
RU94013606A (ru) Гемостимулятор

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties